Literature DB >> 7543827

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion.

K A Pritchard1, L Groszek, D M Smalley, W C Sessa, M Wu, P Villalon, M S Wolin, M B Stemerman.   

Abstract

To examine mechanisms by which native low-density lipoprotein (n-LDL) perturbs endothelial cell (EC) release of superoxide anion (O2-) and nitric oxide (NO), ECs were incubated with n-LDL at 240 mg cholesterol per deciliter for 4 days with media changes every 24 hours. n-LDL increases EC release of O2- by more than fourfold and increases nitrite production by 57%. In the conditioned media from day-4 incubations, n-LDL increases total nitrogen oxides 20 times control EC (C-EC) levels. However, n-LDL did not alter EC NO synthase (eNOS) enzyme activity as measured by the [3H]citrulline assay. N omega-Nitro-L-arginine methyl ester, a specific inhibitor of eNOS activity, increases C-EC release of O2- by > 300% but decreases LDL-treated EC (LDL-EC) release by > 95%. L-Arginine inhibits the release of O2- from LDL-ECs by > 95% but did not effect C-EC release of O2-. Indomethacin and SKF 525A partially attenuate LDL-induced increases in O2- production by approximately 50% and 30%, respectively. Thus, n-LDL increases O2- and NO production, which increases the likelihood of the formation of peroxynitrite (ONOO-), a potent oxidant. n-LDL increases the levels of nitrotyrosine, a stable oxidation product of ONOO-, and tyrosine by approximately 50%. In spite of this increase in oxidative metabolism, analysis of thiobarbituric acid substances reveals that no significant changes in the oxidation of n-LDL occur during the 24-hour incubations with ECs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543827     DOI: 10.1161/01.res.77.3.510

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  78 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Vascular oxidant stress: molecular mechanisms and pathophysiological implications.

Authors:  G Zalba; J Beaumont; G San José; A Fortuño; M A Fortuño; J Díez
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

Review 3.  Flow, NO, and atherogenesis.

Authors:  John P Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

4.  Profound influence of LDL oxidative status and monocyte co-cultures on baboon endothelial activation.

Authors:  Juan Xiao; Vida Hondara; Xing Li Wang; John L Vandeberg; Qiang Shi
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 5.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

8.  Rabbit aortic endothelial dysfunction by low-density lipoprotein is attenuated by L-arginine, L-ascorbate and pyridoxine.

Authors:  Yong Ji; Yi Han; Jianxin Diao; Yan Huang; Qi Chen; Albert Ferro
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

9.  Disrupted NOS signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Sanjeev A Datar; Wenhui Gong; Youping He; Michael Johengen; Rebecca J Kameny; Gary W Raff; Emin Maltepe; Peter E Oishi; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

10.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.